Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

Last updated: March 30, 2026
Sponsor: Alnylam Pharmaceuticals
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neuropathy

Nerve Injury

Amyloidosis

Treatment

N/A

Clinical Study ID

NCT05040373
ALN-TTR02-010
  • Female

Study Summary

The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Documentation that the patient was exposed to patisiran-LNP at any point startingfrom 12 weeks before LMP or at any point during pregnancy

Exclusion

Exclusion Criteria:

  • There are no exclusion criteria for participation in this program.

Study Design

Total Participants: 10
Study Start date:
August 01, 2020
Estimated Completion Date:
October 12, 2030

Connect with a study center

  • Clinical Trial Site

    Nantes,
    France

    Active - Recruiting

  • Clinical Trial Site

    Nantes 2990969,
    France

    Site Not Available

  • Clinical Trial Site

    Münster,
    Germany

    Active - Recruiting

  • Clinical Trial Site

    Münster 2867543,
    Germany

    Site Not Available

  • Clinical Trial Site

    Pavia,
    Italy

    Active - Recruiting

  • Clinical Trial Site

    Pavia 3171366,
    Italy

    Site Not Available

  • Clinical Trial Site

    Groningen,
    Netherlands

    Active - Recruiting

  • Clinical Trial Site

    Groningen 2755251,
    Netherlands

    Site Not Available

  • Clinical Trial Site

    Lisboa,
    Portugal

    Site Not Available

  • Clinical Trial Site

    Lisbon,
    Portugal

    Active - Recruiting

  • Clinical Trial Site

    Lisbon 2267057,
    Portugal

    Site Not Available

  • Clinical Trial Site

    Madrid,
    Spain

    Active - Recruiting

  • Clinical Trial Site

    Madrid 3117735,
    Spain

    Site Not Available

  • Clinical Trial Site

    Iowa City, Iowa 52242
    United States

    Active - Recruiting

  • Clinical Trial Site

    Iowa City 4862034, Iowa 4862182 52242
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.